Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.

Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3-53% in hepatitis C virus...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Julia Dietz, Simone Susser, Caterina Berkowski, Dany Perner, Stefan Zeuzem, Christoph Sarrazin
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Public Library of Science (PLoS) 2015-01-01
Reeks:	PLoS ONE
Online toegang:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0134395&type=printable
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!